Enterococcus faecalis infective endocarditis: a pilot study of the relationship between dura- tion of gentamicin treatment and outcome. Circulation. 2013;127:1810 1817. doi: 10.1161/CIRCULATIONAHA.112.001170. 194. Geraci JE. The antibiotic therapy of bacterial endocarditis: therapeutic data on 172 patients seen from 1951 through 1957: additional observa- tions on short-term therapy (two weeks) for penicillin-sensitive strepto- coccal endocarditis. Med Clin North Am. 1958;42:1101 1140. 195. Miro JM, Pericas JM, del Rio A; Hospital Clinic Endocarditis Study Group. A new era for treating Enterococcus faecalis endocarditis: ampicillin plus short-course gentamicin or ampicillin plus ceftriaxone: that is the question! Circulation. 2013;127:1763 1766. doi: 10.1161/ CIRCULATIONAHA.113.002431. 196. Wilson WR, Wilkowske CJ, Wright AJ, Sande MA, Geraci JE. Treatment of streptomycin-susceptible and streptomycin-resistant enterococcal endocarditis. Ann Intern Med. 1984;100:816 823. 197. Mandell GL, Kaye D, Levison ME, Hook EW. Enterococcal endocardi- tis: an analysis of 38 patients observed at the NewYork Hospital-Cornell Medical Center. Arch Intern Med. 1970;125:258 264. 198. Brandt CM, Rouse MS, Laue NW, Stratton CW, Wilson WR, Steckelberg JM. Effective treatment of multidrug-resistant enterococcal experimental endocarditis with combinations of cell wall-active agents. J Infect Dis. 1996;173:909 913. 199. Gavald J, Torres C, Tenorio C, L pez P, Zaragoza M, Capdevila JA, Almirante B, Ruiz F, Borrell N, Gomis X, Pigrau C, Baquero F, Pahissa A. Efficacy of ampicillin plus ceftriaxone in treatment of experimental endocarditis due to Enterococcus faecalis strains highly resistant to aminoglycosides. Antimicrob Agents Chemother. 1999;43:639 646. 200. Arias CA, Contreras GA, Murray BE. Management of multidrug-resis- tant enterococcal infections. Clin Microbiol Infect. 2010;16:555 562. doi: 10.1111/j.1198-743X.2010.03214.x. 201. Kainer MA, Devasia RA, Jones TF, Simmons BP, Melton K, Chow S, Broyles J, Moore KL, Craig AS, Schaffner W. Response to emerging infection leading to outbreak of linezolid-resistant enterococci. Emerg Infect Dis. 2007;13:1024 1030. doi: 10.3201/eid1307.070019. 202. 